Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The global pharmaceutical analytical testing outsourcing market is expected to reach $9.6 billion by 2025 according to a recent report by Research and Markets.
read more
The global contract manufacturing market size is expected to reach USD 281.6 billion by 2026 registering a CAGR of 7.0%, according to a new report by Grand View Research, Inc. Increasing demand for advanced products is major factor driving the market...
read more
Wednesday, January 18, 2023
Charles River Laboratories International, Inc and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced a viral vector contract development and manufacturing organization...
read more
Lupin and Mylan announced they will partner to commercialize a biosimilar to Enbrel.
read more
Thursday, October 30, 2025
WuXi AppTec has reached a definitive agreement to sell its China-based clinical research services subsidiaries, WuXi Clinical and WuXi MedKey, to Hillhouse Investment Management, a global private asset manager.
read more
BrightInsight announced a global digital health partnership with AstraZeneca.
read more
Sterling Pharma Solutions has started large-scale production of Nanologica’s silica particles.
read more
Friday, February 21, 2020
At the beginning of 2019, the FDA began accepting pilot project proposals to identify solutions for meeting the 2023 requirements of the DSCSA.
read more
Cambrex announced that it is investing approximately $3 million to increase the capacity and efficiency of one of its cGMP manufacturing facilities at its site in Paullo, Milan, Italy.
read more
Biognosys, a provider of proteomics solutions for drug discovery and development, announced the operational readiness of its new proteomics facility in Massachusetts.
read more
Catalent Pharma Solutions, a leading supplier of inhalation drug development, delivery and supply capabilities, today announced that it has entered into a contract with Biota Pharmaceuticals, Inc. (“Biota”), to develop and provide filling and ...
read more
Wednesday, August 27, 2014
Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is collaborating with privately held Australian biomarker research company, ...
read more
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products announced the appointment of Erica Raether as...
read more
Monday, December 02, 2019
Tetra Bio-Pharma has signed a definitive co-development and commercialization agreement with Alternavida for the clinical development, marketing and distribution of CAUMZTM in Mexico.
read more
Tuesday, November 07, 2017
PharmaMar announced a licensing agreement with Boryung Pharm to commercialize the marine-derived anticancer drug Zepsyre, if approved, in South Korea.
read more